Ausgabe 5/2013
Inhalt (7 Artikel)
Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease
Azrin N. Abd Rahman, Susan E. Tett, Christine E. Staatz
Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations
Ibrahim Ince, Catherijne A. J. Knibbe, Meindert Danhof, Saskia N. de Wildt
Single-Center Evaluation of the Single-Dose Pharmacokinetics of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Renal Impairment
Richard A. Preston, Aziz Karim, Caroline Dudkowski, Zhen Zhao, Dyal Garg, Oliver Lenz, Domenic A. Sica
Quantifying the Effect of Covariates on Concentrations and Effects of Steady-State Phenprocoumon Using a Population Pharmacokinetic/Pharmacodynamic Model
Khaled Abduljalil, Simone Lazar, Michael Natanzon, Weidong Wu, Gregor Zadoyan, Benedict Steffens, Victoria Kohl, Klaus Mörike, Dorota Tomalik-Scharte, Julia Stingl, Matthias Schwab, Job Harenberg, Christoph Gleiter, Uwe Fuhr
Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
Janna K. Duong, Shaun S. Kumar, Carl M. Kirkpatrick, Louise C. Greenup, Manit Arora, Toong C. Lee, Peter Timmins, Garry G. Graham, Timothy J. Furlong, Jerry R. Greenfield, Kenneth M. Williams, Richard O. Day
Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment
Michael J. Roy, Keith A. Erdman, Anura T. Abeyratne, Lisa C. Plumb, Kenneth Lasseter, Dennis S. Riff, James J. Keirns
Letter to the Editor: Pharmacokinetics of Non-Intravenous Formulations of Fentanyl
Donald R. Taylor, Allen W. Burton, Nashat Y. Gabrail, Didier Mayeur, Philippe Poulain, Alain Serrie, Luis M. Torres